Biosino Bio-Technology and Science Incorporation (HKG:8247)

Hong Kong · Delayed Price · Currency is HKD

3.200

+0.040 (1.27%)

Jul 31, 2026, 3:55 PM HKT

461.40% (1Y)

Market Cap	463.06M +461.4%
Revenue (ttm)	205.08M -29.9%
Net Income	-56.91M
EPS	-0.39
Shares Out	144.71M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	34,000
Open	3.160
Previous Close	3.160
Day's Range	3.040 - 3.200
52-Week Range	0.570 - 7.000
Beta	0.46
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About HKG:8247

Biosino Bio-Technology and Science Incorporation, together with its subsidiaries, manufactures, sells, and distributes in-vitro diagnostic reagents in Mainland China. The company offers clinical chemistry reagents, including single and double reagents, calibrators, QC products, and washing solution detergents; Elisa kits; rapid tests; and analyzers. It also provides medical and medical inspection services; and produces and sells medical instruments. Biosino Bio-Technology and Science Incorporation Guangdong has a strategic cooperation agreement... [Read more]

Industry Diagnostics & Research

Sector Healthcare

Founded 1988

Employees 450

Stock Exchange Hong Kong Stock Exchange

Ticker Symbol 8247

Full Company Profile

Financial Performance

In 2025, HKG:8247's revenue was 184.29 million, a decrease of -29.95% compared to the previous year's 263.07 million. Losses were -51.14 million, 20.2% more than in 2024.

Financial numbers in CNY Financial Statements